Risdiplam

Category: Genetic Disorders



Risdiplam Overview

Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA)[1][2] and the first oral medication approved to treat this disease.[1][2] Risdiplam is a survival of motor neuron 2-directed RNA splicing modifier.[1][3][4] The most common side effects include fever, diarrhoea, rash, ulcers of the mouth area, joint pain (arthralgia) and urinary...

Read more Risdiplam Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Risdiplam

Recent Risdiplam Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Risdiplam
  • For Solution: 0.75mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Risdiplam or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA